Země: Irsko
Jazyk: angličtina
Zdroj: HPRA (Health Products Regulatory Authority)
DOXAZOSIN MESILATE
PCO Manufacturing
C02CA04
DOXAZOSIN MESILATE
8 Milligram
Tablet Prolonged Release
Product subject to prescription which may be renewed (B)
Alpha-adrenoreceptor antagonists
Authorised
2003-10-17
_ _ PACKAGE LEAFLET : INFORMATION FOR THE USER CARDURA XL 4MG CARDURA XL 8MG PROLONGED-RELEASE TABLETS doxazosin (as mesilate) IMPORTANT THINGS THAT YOU SHOULD KNOW ABOUT YOUR MEDICINE: • Cardura XL is a treatment for high blood pressure • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. • You should take Cardura XL regularly to get the maximum benefit, even if you are feeling well. • Most people do not have serious problems when taking Cardura XL but side effects can occur – see Section 4 for details. If you experience swelling of the face, tongue or windpipe, see your doctor immediately. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. • Taking other medicines may sometimes cause problems. Check with your doctor or pharmacist before taking this or any other medicines. • If you are, or are trying to become, pregnant, do not take Cardura XL and tell your doctor. Please read the rest of this leaflet. It includes other important information on the safe and effective use of this medicine that might be especially important to you. If you have any further questions, ask your doctor or pharmacist. IN THIS LEAFLET: 1. What Cardura XL is and what it is used f Přečtěte si celý dokument
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Cardura XL 8mg Prolonged -release tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 8mg doxazosin (as mesilate). For a full list of excipients see section 6.1 3 PHARMACEUTICAL FORM Prolonged-release tablet _Product imported from the Netherlands, UK and Spain:_ White, round, biconvex shaped tablets with an orifice in one side, marked ‘CXL 8’ on one side, plain on the other. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Cardura XL is indicated for the treatment of hypertension and can be used as a sole agent to control blood pressure in hypertensive patients. In patients inadequately controlled on single antihypertensive therapy, Cardura XL may be used in combination with a thiazide diuretic, beta-adrenoceptor blocking agent, calcium antagonist or an angiotensin-converting enzyme inhibitor. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The initial dose of Cardura XL is 4mg once daily. A significant number of patients will be controlled on this dose. If necessary, the dosage may be increased to 8mg once daily according to patient response. The maximum recommended dose is 8mg once daily. Cardura XL can be taken with or without food. The tablets should be swallowed whole with a sufficient amount of liquid. They should not be cut or chewed. _ELDERLY_: In common with other drugs of this class, the dosage should be kept as low as possible and increments made under close supervision. _USE IN RENALLY-IMPAIRED PATIENTS _: Since the pharmacokinetics of doxazosin are unchanged in patients with renal insufficiency, and there is no evidence that doxazosin aggravates existing renal dysfunction, the usual dosages may be used in these patients. Cardura XL is not dialysable. _USE IN HEPATICALLY Přečtěte si celý dokument